Clinical studies on combination therapy of jinlong capsule and transarterial chemoembolization in treatment of primary hepatic carcinoma

Chinese Journal of Cancer Prevention and Treatment

Volumn 15, Issue 18, 2008, Pages 1416-1418

  Jia, Chang He ^a   Wang, Wen Yu ^a   Kang, Yi ^a  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Capsules; Chemoembolization, therapeutic; Hepatic artery; Liver neoplasms combination of chinese medicine and western medicine; Therapeutic uses

Indexed keywords

CHINESE DRUG; JINLONG; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHEMOEMBOLIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG CAPSULE; FEMALE; HUMAN; LIVER CARCINOMA; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TUMOR VOLUME;

EID: 77953434416     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Chinese source.
2. Chinese source.
3. Therasse P, Arbuck S G, Eisenhauer E A, et al. New guidelines to evaluate the response to treatment in solid tumors[J]. J Natl Cancer Inst, 2000, 92(3): 205.
4. Chinese source.
5. Cho Y K, Chung J W, Kim J K, et al. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization[J]. Cancer, 2008, 112(2): 352-361.
6. Vogl T J, Zangos S, Balzer J O, et al. Transarterial chemoembolization (TACE) in hepatocellular carcinoma: technique, indication and results[J]. Rofo, 2007, 179(11): 1113-1126.
7. Chinese source.